An opioid that Avenue Therapeutics reformulated for treating post-surgical pain in hospital settings has been rejected by the FDA due to safety concerns. The Avenue (NASDAQ: ATXI) drug is an intravenous formulation of tramadol, an opioid that first reached …
See Original Article

Key Takeaways: Recent uptick in rates might spell better times ahead for banks; Credit loss provisions still expected to weigh, but cost-cutting has likely helped; Housing market seen aiding Wells, while Citigroup’s C -1.1% credit card business stays in focus.
See Original Article

KPMG is the seventh-largest accounting practice in Sacramento, ranked by number off certified public accountants, according to the 2020 list of
See Original Article

OncoSec Medical Inc., a Pennington-based cancer immunotherapy company, has named a chief clinical development officer to oversee the company’s trial of a product that is designed to work with Merck’s Keytruda to fight melanoma. Sandra Aung will serve …
See Original Article

Swiss Re and Daimler Insurance Services have entered into a strategic partnership for automotive and mobility insurance and launched a new managing general agent called Movinx. The aim of the 50/50 joint venture is to develop fully digital automotive and …
See Original Article